Radiofrequency Ablation Devices Market Expand Their Businesses With New Investments

Global radiofrequency ablation devices market is expected to reach USD 8.85 billion by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of target disorders related to pain such as BPO (benign prostatic obstruction) and osteoporosis pain and growing global geriatric population base is expected to serve this market as high impact rendering drivers. Technology innovation in each product segment in terms of cost effectiveness and user friendliness is also expected to further market demand.

Surgical oncology dominated the overall market in terms of share and was valued at over USD 1 billion in 2013 majorly on account of high procedure volumes and cancer prevalence. However, the radiofrequency ablation devices for hypertension market on account of increasing demand from patients and subsequent increase in R&D initiatives is expected to grow at the fastest CAGR during the forecast period.

To request a sample copy or view summary of this report: 
https://www.grandviewresearch.com/industry-analysis/radiofrequency-ablation-devices-market

Further key findings from the study suggest:

• Global radiofrequency ablation devices market was 19,619.0 thousand units in 2013 and is expected to reach 78,899.1 thousand units by 2020, growing at a CAGR of 22.0% over the next six years.
• Disposable radiofrequency ablation devices accounted for the largest market share in 2013 and are expected to grow at a CAGR over 20.0% from 2014 to 2020. Increasing government initiatives aimed at curbing post-surgery hospital acquired infections and cost effectiveness associated with these products are two factors accounting for its rapid growth.
• North America, owing to the presence of high healthcare expenditure, sophisticated healthcare infrastructure and increasing prevalence of pain related problems dominated the overall market in terms of revenue in 2013. As per the Community Chiropractic Centre report, over 31.0% of Americans suffer from back pain problems and such large presence of target patients is expected to boost the demand for radiofrequency ablation devices in the region.
• The Asia Pacific radiofrequency ablation devices market is expected to grow at a CAGR of over 20.0% during the forecast period. Rapidly growing economic conditions and improving healthcare infrastructure in the emerging markets of China and India are expected to present the market with lucrative growth opportunities. Introduction of technological advancements such as multi needle electrode on the grounds of accuracy, portability and cost effectiveness is also expected to serve this market as a driver by catering to changing customer requirements.
• Some key market players of radiofrequency ablation devices include Stryker Corp., Accuray, St. Jude Medical Inc., Neurotherm Inc., Biosense Webster, Diros Technology Inc., Cosman Medical Inc. and Kimberly-Clark Corporation.
• The market is marked by the presence of strategic mergers and acquisitions aimed at improving distribution networks, product portfolio and regional presence. For example, Stryker Corporation announced the acquisition of Berchtold Holding AG in April 2014. This initiative is expected to strengthen Stryker Corporation’s presence in the business segment catering to radiofrequency ablation devices based chronic pain management.

Access Press Release Of This Research Report by Grand View Research: https://www.grandviewresearch.com/press-release/global-radiofrequency-ablation-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Key Factors that Drive & Impede the Growth of World LNG Market

The global liquid natural gas (LNG) market is expected to reach USD 20.6 billion by 2025, growing at a CAGR of 12.7%, according to a new report by Grand View Research, Inc. Rising focus on development and expanding gas pipeline infrastructure and growing demand for natural gas from downstream sectors is a crucial driving factor for the industry.

Decreasing LNG prices along with execution of favorable government rules and regulations, which are attracting FDIs & tax schemes are also conducive to industry growth. Cumulative emphasis of adequate support infrastructure in numerous economies is anticipated to enhance product demand in the construction sector, since the product is used in building equipment.

On the contrary, insufficient channel infrastructure is supplementing demand for small scale projects to source natural gas for key consumers in remote areas, specifically in the power generation and industrial manufacturing verticals. Rapid urbanization, industrialization and increasing projects supporting power, gas & petrochemical distribution are projected to positively provide stimulus to the industry.

Power generation accounted for 46% of the volume share in 2016, and is anticipated to grow at over 6.9% CAGR from 2017 to 2025. Power generation plants are gradually shifting from naphtha-based feedstock towards LNG in order to provide cost-competitiveness and enhanced delivery times while also receiving support in the form of favorable regulations encouraging these trends.

To request a sample copy or view summary of this report: 
https://www.grandviewresearch.com/industry-analysis/liquefied-natural-gas-lng-market

Further key findings from the report suggest:

• The global LNG market demand exceeded 265 million tons in 2016 and is expected to grow at a CAGR of 6.5% from 2017 to 2025
• Transportation is emerged as the largest application in 2016 and is estimated to generate revenue over USD 3.6m billion by 2025 owing to widespread adoption of sustainable resources in place of conventional fuels
• Prices in North America are expected to be dependent upon the Henry Hub model, while demand in South Africa is likely to continue being unpredictable on account of civil unrest and fluctuating supply dynamics
• Europe is likely to witness moderate progress with rising competition from Russia and Norwegian piped natural gas (PNG). Africa is expected to remain a rapidly developed market with new production strategies in the Cameroon and development anticipated in Mozambique.
• Asia Pacific consumption patterns are projected to remain exponentially high over the next decade owing to various developments across emerging economies, especially in the power generation and transportation market. The region is expected to grow at a CAGR of 6.5% from 2016 to 2025
• Key players including Chevron, Exxon Mobil, PetroChina, Total SA, Stat oil, Eni S.p.A., BP plc, Royal Dutch Shell, Conoco Philips and CPCC dominated the sector accounting for over 60% of the total volume in 2016

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/liquefied-natural-gas-lng-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Healthcare Analytics Market Growth, Industry Trends to 2025

The global healthcare/medical analytics market is expected to reach USD 53.65 billion by 2025, according to a new report by Grand View Research, Inc. Increasing need to reduce healthcare expenditure among hospitals, and other healthcare providers is anticipated to boost growth in the market 

With the advent of data-enriched tools such as mHealth, eHealth, Electronic Health Records (EHR), and mobile applications, the communication gap between caregivers and patients has reduced. These tools generate tremendous data, which can be used for personalized treatments.

Generally, patients may hesitate to use these tools, which might affect the implementation of analytics. However, with the combination of artificial and human intelligence data analytics, which offer wide opportunities to further customize medical approaches, the demand for these tools is anticipated to increase over the forecast period.

Hospitals are now using healthcare analytics to manage the number of workers working in a particular shift, for instance, a hospital in Paris uses healthcare analytics to predict the number of patients that may be hospitalized. This data can be used to decide the number of staff members that will be needed for a particular shift, which helps in reducing labor cost in hospitals.

To request a sample copy or view summary of this report: 
https://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market

Further key findings from the report suggest: 

• Descriptive analytics held a significant share in 2015 owing to its applications in process optimization in organizations.
• The services category dominated the component segment in 2015. Outsourcing of these big data services contributed towards their growth in leading to the high volume of services rendered.
• The hardware systems category dominated the component segment, high-cost of the hardware contribute to its growth.
• On-premise delivered analytic services dominated the delivery mode category with around 54.0% share in 2015.
• Operational and administrative applications governed the applications segment and held a remunerative share in the year, 2015.
• Payers held a significant market share in 2015 and the providers are anticipated to grow at a lucrative rate.
• North America captured a significant share in the global market. Advanced healthcare infrastructure in this region and the growing per capita healthcare expenditure supported the greater consumption of these services.
• The Asia Pacific region is expected to witness gainful growth attributable to the untapped opportunities in the countries including India and China.
• Some key players operating in the healthcare analytics market include IBM Corporation, Oracle Corporation, SAS, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Optum Health, Inc., and Verisk Analytics, Inc. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments directed towards R&D efforts.                                                                                                        

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-healthcare-analytics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Technology Leader Driving Artificial Pancreas Device System Innovations

The global artificial pancreas device system market is anticipated to reach USD 390.4 million by 2024, according to a new report by Grand View Research, Inc. Increasing prevalence of diabetes, intensive R&D efforts by industry players, and rising demand for automated systems for glycemic control are the key factors that are driving the market growth. 

Regulatory bodies such as FDA are continuously approving new and innovative products which is increasing the reach of the companies in various market. For instance, in December 2016, OneTouch Vibe plus Insulin Pump by Animas received FDA approval and Health Canada License for the sale of the product. In January 2016, Animas received FDA approval for Animas Vibe Insulin Pump, the device to manage of diabetes in children and adolescents.

Similarly, in June 2016, Tandem Diabetes Care cleared its FDA approval for remote software update tool for insulin pump. Also, in September 2016, the company received FDA approval for their product t:slim G4 Insulin Pump giving the diabetes community a powerful new tool to help simplify therapy management Such factors are contributing to the growth of the market.

Additionally, the prevalence of diabetes is increasing in low and middle-income counties owing to the sedentary lifestyle, genetic modification, obesity, lack of physical activity, and unhealthy diet. According to the data published by the International Diabetes Federation(IDF), in 2015 there were about 415 million people suffering from diabetes globally. Also, Based on the information provided by the American Diabetes Association, in 2012, about 29.1 million Americans suffered from diabetes out of which 90% were of type2 and 1.25 million suffered from type 1 diabetes. Furthermore, the increasing dependency of type 2 diabetes on insulin is expected to create opportunities for the artificial pancreas devices market.

To request a sample copy or view summary of this report: 
https://www.grandviewresearch.com/industry-analysis/artificial-pancreas-device-market

Further Key Findings From the Study Suggest:

• Control to Target (CTT) systems is anticipated to witness fastest growth during the forecast period as they are fully automated and require no intervention on the patient’s part for the administration of insulin or for the monitoring of glucose levels.
• Asia Pacific artificial pancreas device system market is expected to grow with the highest CAGR over the forecast period owing to the lifestyle, genetic modification, urbanization and aging population.
• Major players of the market include, Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc., TypeZero Technologies, LLC, and Beta Bionics.

Access Press Release Of This Research Report by Grand View Research: https://www.grandviewresearch.com/press-release/global-artificial-pancreas-device-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Clinical Trial Management System Market: Opening Airways and Opportunities

The global CTMS market is expected to reach USD 2.26 billion by 2024, according to a new report by Grand View Research, Inc. Rising research activities and increasing complexity in data management for multiple verticals such as pharmaceutical and biotechnology are anticipated to present the clinical trial management system market with lucrative opportunities over the forecast period. These systems are capable for speeding up the research activity along with cost containment which is crucial for pharmaceutical companies that invest a lot on R&D innovation. 

The growth in certain sectors such as investment in R&D segment and the increase in the number of registered clinical trials are also certain leading causes in the growth and adoption of the CTMS solutions. Companies such as Oracle corporation, Parexel International Corporation and Medidata solutions Inc. all the three based out of U.S are the leaders in the market of CTMS market globally as of 2016.

Increase in the number of clinical trials can be attributed to the implementation of CTMS. Consequently, the number of clinical trials conducted in multiple regions has increased. Demand for managing data obtained from such trials to compare, overlap, and process is high. As a result, adoption of CTMS is rapidly increasing

To request a sample copy or view summary of this report: 
https://www.grandviewresearch.com/industry-analysis/clinical-trial-management-system-ctms-market

Further key findings from the report suggest:

• The global enterprise CTMS market is anticipated to reach 1.4 billion by 2024, at a CAGR of 14.3% from 2016 to 2024
• In terms of delivery mode, web based CTMS dominate the market as of 2016 with a market share of more than 75.0%
• Cloud based CTMS is expected to show the fastest growth over the forecast period and contribute over 15.0% share by 2024.
• Pharmaceutical & biotechnology firms held more than 40.0% share in 2016 and is expected to contribute highest revenue over the forecast period
• North America is expected to dominate the healthcare biometric market during the forecast period
• Asia Pacific is projected to drive the market growth and provide numerous opportunities to industry players. The efforts by government officials and research industry towards improving infrastructure, rising number of research studies and digitalization coupled with centralization of the management systems are expected to propel the demand for CTMS over the forecast period.
• Some of the key companies present in the market include Forte Research Systems Inc., Bioclinica, Oracle Corporation, eClinForce Inc., Medidata Solutions, DATATRAK, Guger Technologies, PARAXEL International Corporation, and MedNet Solutions, Inc. Other participants include; ChemWare Inc., iWEb Technologies, Data MATRIX, Jade Global Solutions, Integrated Clinical Solutions, and MAJARO InfoSystems.

Access Press Release Of This Research Report by Grand View Research: https://www.grandviewresearch.com/press-release/global-clinical-trial-management-system-ctms-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com